Our People
George Neville-Jones
Chief Executive Officer
Natalio Krasnogor
Chief Technology Officer
Nadia Rostami
Chief Scientific Officer
Leanne Hobbs
Chief Digital Officer
We will set the global standard in the management of provenance and integrity for biological assets; enabling the potential of synthetic biology to be realised worldwide
Traceability, transparency, and ultimately trustworthiness are required from cradle to grave for engineered cell lines. We will utilise our proprietary DNA Barcodes to ensure the absolute integrity of biological assets - proof of ownership, clear records of provenance and robust traceability
Biological assets already underpin many key industries and their importance is accelerating. Synthetic biology is a key focus area for UK Research & Innovation. It involves the study and manipulation of genomes to optimise biological assets for their intended use
Full-stack biotechnology platforms for cell line (re) programming are on the horizon, thanks mostly to (a) advances in gene synthesis techniques as well as (b) the growing integration of life science research with informatics, the internet of things, and automation. These emerging platforms will accelerate the production and consumption of biological products
Chief Executive Officer
Chief Technology Officer
Chief Scientific Officer
Chief Digital Officer